02181.HK
Mabpharm Limited
HKSE · Healthcare · Biotechnology · CN
HKD 0.43
−1.15%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 17.84x
- PEG TTM
- —
- Price / book
- 7.78x
- Price / sales
- 1.97x
- Price / cash flow
- 15.16x
Enterprise value
- Enterprise value
- HKD 2.0B
- EV / sales
- 2.25x
- EV / EBITDA
- 17.84x
- EV / EBIT
- 47.04x
- Market cap
- HKD 1.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026